Multimedia content is supported by an unrestricted educational grant from:

Scientific Agenda

Session IIB: The current state of antifungals (recent developments and happenings): The academic perspective
Moderator: Michael A. Pfaller, MD

Thoughts from an academician
Thomas F. Patterson, MD, FACP